Financhill
Sell
40

UNPRF Quote, Financials, Valuation and Earnings

Last price:
$43.94
Seasonality move :
-13.76%
Day range:
$43.94 - $43.94
52-week range:
$43.74 - $91.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.55x
P/B ratio:
24.96x
Volume:
--
Avg. volume:
37
1-year change:
-52.14%
Market cap:
$366B
Revenue:
--
EPS (TTM):
--
Period Ending 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Revenue $108.4B $73.7B $58.2B $192.8B $289.1B
Revenue Growth (YoY) 32.52% -32.05% -20.99% 231.27% 49.93%
 
Cost of Revenues $105.1B $70.9B $55.6B $185B $292.2B
Gross Profit $3.3B $2.8B $2.6B $7.8B -$3.1B
Gross Profit Margin 3.08% 3.8% 4.45% 4.04% -1.06%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $3.6B $3.4B $2.8B $2.9B $3.6B
Operating Income -$236.2M -$595.6M -$237.5M $4.9B -$6.7B
 
Net Interest Expenses $405M -- $67.4M -- $472.5M
EBT. Incl. Unusual Items -$590.4M $1.1B $617.8M -$5.4B -$13.7B
Earnings of Discontinued Ops. -- -- -- -$42.6M -$5.1B
Income Tax Expense -$69.7M $352.6M $158.7M -$586.9M $1.4B
Net Income to Company -$521.9M $721M $459.1M -$4.8B -$15.1B
 
Minority Interest in Earnings $47.2M -$38.1M -$6.9M -$74.5M $152.9M
Net Income to Common Excl Extra Items -$473.5M $682.9M $453.4M -$4.9B -$20B
 
Basic EPS (Cont. Ops) -$1.30 $1.87 $1.23 -$13.48 -$34.85
Diluted EPS (Cont. Ops) -$1.30 $1.87 $1.23 -$13.48 -$34.85
Weighted Average Basic Share $366M $366M $366M $366M $574.2M
Weighted Average Diluted Share $366M $366M $366M $366M $574.2M
 
EBITDA $1.7B $3.3B $2.2B -$4.2B -$10.3B
EBIT -$144.1M $1.3B $1B -$5.2B -$12.8B
 
Revenue (Reported) $108.4B $73.7B $58.2B $192.8B $289.1B
Operating Income (Reported) -$236.2M -$595.6M -$237.5M $4.9B -$6.7B
Operating Income (Adjusted) -$144.1M $1.3B $1B -$5.2B -$12.8B
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Revenue $14.6B $12.7B $43.7B $94.2B $22.7B
Revenue Growth (YoY) -26.61% -13.02% 244.37% 115.74% -75.9%
 
Cost of Revenues $14.2B $12.3B $41.8B $96.7B $22B
Gross Profit $372.5M $390.6M $1.9B -$2.5B $754.5M
Gross Profit Margin 2.55% 3.08% 4.3% -2.6% 3.32%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $301.3M $824.4M $9.2B $29.5B $358.2M
Operating Income $71.2M -$433.8M -$7.4B -$32B $396.3M
 
Net Interest Expenses -- -- -- $77.6M --
EBT. Incl. Unusual Items $86.7M -$341.5M -$7.4B -$32B $473.6M
Earnings of Discontinued Ops. -- -- -- $22.2M --
Income Tax Expense $18.9M -$72.5M -$1.8B -$3.8B $102.3M
Net Income to Company $56.1M -$224M -$5.6B -$27.5B $357.9M
 
Minority Interest in Earnings -$4.4M -$26.9M -$16.5M -$6M $4.4M
Net Income to Common Excl Extra Items $63.4M -$297M -$5.6B -$28.2B $377.8M
 
Basic EPS (Cont. Ops) $0.17 -$0.81 -$15.34 -$76.97 $0.04
Diluted EPS (Cont. Ops) $0.17 -$0.81 -$15.34 -$76.97 $0.04
Weighted Average Basic Share $380M $368.1M $366M $8.3B $8.7B
Weighted Average Diluted Share $380M $368.1M $366M $8.3B $8.7B
 
EBITDA $372.5M -$120.4M -$6.9B -$31.6B $779.6M
EBIT $153.4M -$313.4M -$7.3B -$31.9B $569.4M
 
Revenue (Reported) $14.6B $12.7B $43.7B $94.2B $22.7B
Operating Income (Reported) $71.2M -$433.8M -$7.4B -$32B $396.3M
Operating Income (Adjusted) $153.4M -$313.4M -$7.3B -$31.9B $569.4M
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Revenue $97B $55.7B $117.6B $321.2B $144.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $94.5B $53.4B $112.7B $317.3B $144.4B
Gross Profit $2.4B $2.3B $4.9B $3.9B $399.9M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $465.3M $3.7B $13.4B $47B -$49.8B
Operating Income $2B -$1.3B -$8.5B -$43.1B $50.2B
 
Net Interest Expenses $415.2M -- -- $1.1B --
EBT. Incl. Unusual Items $1.6B $333.3M -$7.5B -$45.1B $44.4B
Earnings of Discontinued Ops. -- -- -- -$657.2M -$4.3B
Income Tax Expense $394.3M $229.9M -$1.8B -$5B $7.8B
Net Income to Company $1.2B $151.7M -$5.7B -$39.3B $35.7B
 
Minority Interest in Earnings $24.5M -$52.1M -$10M $72.4M $61.4M
Net Income to Common Excl Extra Items $1.2B $51.2M -$5.7B -$40.7B $32.3B
 
Basic EPS (Cont. Ops) $3.34 $0.15 -$15.53 -$111.31 $3.88
Diluted EPS (Cont. Ops) $3.34 $0.15 -$15.53 -$111.31 $3.88
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $3.5B $2.6B -$5.8B -$42B $47.4B
EBIT $2.2B $474M -$7.1B -$44.8B $45.5B
 
Revenue (Reported) $97B $55.7B $117.6B $321.2B $144.8B
Operating Income (Reported) $2B -$1.3B -$8.5B -$43.1B $50.2B
Operating Income (Adjusted) $2.2B $474M -$7.1B -$44.8B $45.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $34.7B $93.6B $224.6B $81.6B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $33.1B $89.7B $224.5B $78.3B --
Gross Profit $1.6B $3.9B $112.8M $3.2B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.1B $11.6B $46.1B -$7.7B --
Operating Income $502.4M -$7.7B -$46B $10.9B --
 
Net Interest Expenses $87.2M -- $1.2B $99.3M --
EBT. Incl. Unusual Items $588M -$7.5B -$47.1B $10.9B --
Earnings of Discontinued Ops. -- -- -$657.2M -- --
Income Tax Expense $112.5M -$1.8B -$6.2B $382.2M --
Net Income to Company $521.6M -$5.6B -$40.1B $10.7B --
 
Minority Interest in Earnings -$66.5M -$73.1M $74.7M -$18.3M --
Net Income to Common Excl Extra Items $410M -$5.7B -$41.5B $10.5B --
 
Basic EPS (Cont. Ops) $1.12 -$15.56 -$113.38 $1.26 --
Diluted EPS (Cont. Ops) $1.12 -$15.56 -$113.38 $1.26 --
Weighted Average Basic Share $1.1B $1.1B $9.1B $25.3B --
Weighted Average Diluted Share $1.1B $1.1B $9.1B $25.3B --
 
EBITDA $1.5B -$6.5B -$44.6B $12.9B --
EBIT $702.1M -$7.4B -$46.9B $11.4B --
 
Revenue (Reported) $34.7B $93.6B $224.6B $81.6B --
Operating Income (Reported) $502.4M -$7.7B -$46B $10.9B --
Operating Income (Adjusted) $702.1M -$7.4B -$46.9B $11.4B --
Period Ending 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Cash and Equivalents $1.6B $975.7M $355.5M $3.4B $5B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $9.6B $7.9B $8B $13.2B $10.3B
Inventory $1.9B $1.7B $1.4B $2.1B $5.1B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.3B $1.4B $2.5B $2.1B $1.7B
Total Current Assets $30.6B $22.4B $22.9B $103.4B $68.4B
 
Property Plant And Equipment $12.1B $11.4B $12B $9.7B $8.4B
Long-Term Investments -- -- -- -- --
Goodwill $2.1B $2.1B $2.2B $2B --
Other Intangibles $876.2M $833.4M $902.8M $2.4B $2.2B
Other Long-Term Assets $257.4M $175.9M $223.9M $285.3M $245.6M
Total Assets $58.3B $49B $49.5B $145.4B $130.3B
 
Accounts Payable $9.4B $8.2B $8.4B $13.1B $10B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1.9B $1.5B $1.4B $1.6B $908.3M
Total Current Liabilities $30.6B $21.1B $22.1B $108.1B $61.6B
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $45.1B $35.6B $35.7B $137.7B $125.5B
 
Common Stock $711.5M $696.7M $765M $704.2M $15.2B
Other Common Equity Adj -- -- -- -- --
Common Equity $12.6B $12.8B $13.2B $7.1B $4.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $568.5M $622.8M $537.5M $549.1M $208M
Total Equity $13.2B $13.4B $13.8B $7.7B $4.7B
 
Total Liabilities and Equity $58.3B $49B $49.5B $145.4B $130.3B
Cash and Short Terms $1.6B $975.7M $355.5M $3.4B $5B
Total Debt -- -- -- -- --
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Cash and Equivalents $427.8M $729.1M $2.1B $2.2B $4.6B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $15B $6.1B $8.3B $10.1B $6.1B
Inventory $2.1B $1.9B $3B $6.2B $3.4B
Prepaid Expenses -- -- -- -- --
Other Current Assets -- $1.6B $1.9B $1.8B $1B
Total Current Assets $18.3B $18.4B $102B $133.2B $36.2B
 
Property Plant And Equipment $11.8B $11.2B $11.4B $10.1B $8.4B
Long-Term Investments -- -- -- -- --
Goodwill $2.1B $2.1B $2.1B -- --
Other Intangibles $811.8M $855.9M $834M $691M --
Other Long-Term Assets -$1.1M $177.3M $284.2M $245.7M $173.6M
Total Assets $44.5B $43.8B $167.5B $248.1B $62.7B
 
Accounts Payable $14.9B $7.1B $8.9B $10.2B $5.9B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -$1.1M $1.4B $1.8B $995.7M $875.4M
Total Current Liabilities $17.5B $17.1B $109.4B $147.6B $28.1B
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $31.2B $31B $160B $279B $47.8B
 
Common Stock $680.5M $730.3M $721.5M $611.4M $15B
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $632.4M $567.1M $593.9M $523.9M $235M
Total Equity $13.3B $12.8B $7.5B -$30.9B $14.9B
 
Total Liabilities and Equity $44.5B $43.8B $167.5B $248.1B $62.7B
Cash and Short Terms $427.8M $729.1M $2.1B $2.2B $4.6B
Total Debt -- -- -- -- --
Period Ending 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Net Income to Stockholders -$521.9M $721M $459.1M -$4.8B -$15.1B
Depreciation & Amoritzation $1.8B $2B $1.2B $1.1B $2.6B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$8.8B $5.6B $3.5B -$90.4B $7.1B
Change in Inventories -$114.5M $207.1M $343.8M -$771.4M -$3.4B
Cash From Operations $1.5B $1B $1.4B $4.3B -$16B
 
Capital Expenditures $753.4M $733.3M $828M $685.1M $551.6M
Cash Acquisitions -- $363.8M $61.7M $43.8M $35.9M
Cash From Investing -$1.5B $246.3M -$1.3B -$8.9B $1.3B
 
Dividends Paid (Ex Special Dividend) -$356.6M -$404.1M -$512.8M -$592.8M -$27.4M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -$8.3M -$6.3M
Other Financing Activities $716.8M -$1.3B -$267.2M $8.4B $2.7B
Cash From Financing $376.7M -$1.7B -$775.4M $7.8B $16.9B
 
Beginning Cash (CF) $1B $1.3B $942.2M $287.5M $3.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $350.7M -$363.8M -$646.4M $3.1B $2.2B
Ending Cash (CF) $1.3B $923.6M $277.5M $3.5B $4.8B
 
Levered Free Cash Flow $712M $310.1M $589.3M $3.6B -$16.5B
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Net Income to Stockholders $56.1M -$224M -$5.6B -$27.5B $357.9M
Depreciation & Amoritzation $214.9M $231.2M $407.1M $161.2M $208.1M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- $4.3B -$77.5B -$30.6B $10.1B
Change in Inventories -- $295.7M -$879.5M -$2.5B $97.6M
Cash From Operations $53.7M $656.9M $2.2B -$8.6B $2.8B
 
Capital Expenditures $175.2M $269.3M $204.6M $158.4M $171.6M
Cash Acquisitions -$121.5M $64.6M $37.6M $17.8M -$11.2M
Cash From Investing -$159.2M -$525.8M -$4B -$2.5B $422.4M
 
Dividends Paid (Ex Special Dividend) -$14M -$29.7M $31.2M $1.5M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $5.8B $10.3B $164.1M
Long-Term Debt Repaid -- -- -$363.1M -$10.7M -$4.1B
Repurchase of Common Stock -- -- -- -- $11.6K
Other Financing Activities -$248.6M -$339.3M -$2.1B -$3.4M -$1.7K
Cash From Financing -$262.7M -$368.8M $3.3B $10.2B -$3.9B
 
Beginning Cash (CF) $752.7M $633.3M $477.3M $3.2B $5.4B
Foreign Exchange Rate Adjustment $3.3M -$10.9M $2.1M $21M $33.7M
Additions / Reductions -$368.1M -$237.6M $1.6B -$874.3M -$663.5M
Ending Cash (CF) $375.8M $442M $2.1B $2.2B $4.7B
 
Levered Free Cash Flow -$121.4M $387.7M $2B -$8.7B $2.7B
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Net Income to Stockholders $1.2B $151.7M -$5.7B -$39.3B $35.7B
Depreciation & Amoritzation $1.4B $2.2B $1.2B $2.4B $2B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -$114.4B -$94.1B $183B
Change in Inventories -- -- -$1.2B -$3.5B $2.8B
Cash From Operations $1.1B $2.3B $3.1B -$9.3B $2.5B
 
Capital Expenditures $754M $847.4M $882.1M $412.6M $636.7M
Cash Acquisitions $349.2M $67.2M $53.8M $24.5M $197.8M
Cash From Investing $377M -$1B -$6.3B -$5.4B $6.9B
 
Dividends Paid (Ex Special Dividend) -$406.5M -$530.4M -$593.6M -$28.3M -$1.2M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- -$13.9M
Other Financing Activities -$1.6B -$734.9M -$56.7M $8.3B $2.7B
Cash From Financing -$1.9B -$1.3B $4.8B $15.2B -$6.6B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$512.6M $33.8M $1.6B $526.1M $2.7B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $299.9M $1.5B $2.2B -$9.7B $1.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $521.6M -$5.6B -$40.1B $10.7B --
Depreciation & Amoritzation $850.2M $826.5M $2.1B $1.6B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $6.2B -$111.7B -$115.4B $60.6B --
Change in Inventories -$104.1M -$1.6B -$4.4B $1.8B --
Cash From Operations $974.1M $2.6B -$11B $7.5B --
 
Capital Expenditures $557.8M $611.9M $339.5M $424.6M --
Cash Acquisitions $50.3M $42.4M $23.2M $185.1M --
Cash From Investing -$764.8M -$5.7B -$2.2B $3.3B --
 
Dividends Paid (Ex Special Dividend) -$509.9M -$590.7M -$26.2M -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $5.8B $14.2B $6.8B --
Long-Term Debt Repaid -- -$363.1M -$1.8B -$18B --
Repurchase of Common Stock -- -- -- -$7.6M --
Other Financing Activities -$210.5M $0 -$51.4M $1.1M --
Cash From Financing -$715.7M $4.9B $12.3B -$11.2B --
 
Beginning Cash (CF) $3B $1.8B $10.8B $15B --
Foreign Exchange Rate Adjustment -$17.5M $11.8M $115.8M $53.4M --
Additions / Reductions -$506.4M $1.8B -$857.3M -$389.8M --
Ending Cash (CF) $2.5B $3.6B $9.7B $14.8B --
 
Levered Free Cash Flow $416.3M $2B -$11.3B $7.1B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock